Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | NCF1 | P14598 | 2/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.32 |
| ▸ | MAOA | P21397 | 2/20 | 0.32 |
| ▸ | MAOB | P27338 | 2/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27166248 | 0.83 | HRH3 (0.58) | HRH3LTA4HMAOAMAOB | |
| SCHEMBL27166283 | 0.83 | HRH3 (0.58) | HRH3LTA4HMAOAMAOB | |
| SCHEMBL27166299 | 0.82 | HRH3 (0.59) | HRH3LTA4HNCF1MAOAMAOB | |
| SCHEMBL27166232 | 0.74 | HRH3 (0.58) | HRH3LTA4HMAOAMAOB | |
| SCHEMBL27166281 | 0.74 | HRH3 (0.58) | HRH3LTA4HMAOAMAOB | |
| SCHEMBL27268715 | 0.74 | HRH3 (0.58) | HRH3LTA4HMAOAMAOB | |
| SCHEMBL14117415 | 0.71 | NCF1 (0.45) | HRH3NCF1 | |
| SCHEMBL27166279 | 0.70 | HRH3 (0.66) | HRH3LTA4HMAOAMAOB | |
| SCHEMBL27166233 | 0.70 | HRH3 (0.58) | HRH3LTA4HMAOAMAOB | |
| SCHEMBL11384767 | 0.69 | NCF1 (0.43) | HRH3NCF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584251-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | Bayer Aktiengesellschaft (DE) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024052549-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024052549-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | disclosed |
| EP-4335840-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | Bayer Aktiengesellschaft (DE) | 2024-03-13 | — | — | EP | disclosed |